Polyzos et al. performed a meta-analysis including 33 studies and 2,612 subjects found that increased leptin levels were indeed more prevalent in patients with NAFLD than the controls, and higher circulating leptin levels were correlated with increased severity of NAFLD (37). The gene discussed is LEP; the disease is metabolic dysfunction-associated steatotic liver disease.